Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Adv Biol Regul. 2023 Jan;87:100938. doi: 10.1016/j.jbior.2022.100938. Epub 2022 Nov 30.
The peptidyl-prolyl isomerase Pin1 cooperates with proline-directed kinases and phosphatases to regulate multiple oncogenic pathways. Pin1 specifically recognizes phosphorylated Ser/Thr-Pro motifs in proteins and catalyzes their cis-trans isomerization. The Pin1-catalyzed conformational changes determine the stability, activity, and subcellular localization of numerous protein substrates. We conducted a survey of eukaryotic protein kinases that are regulated by Pin1 and whose Pin1 binding sites have been identified. Our analyses reveal that Pin1 target sites in kinases do not fall exclusively within the intrinsically disordered regions of these enzymes. Rather, they fall into three groups based on their location: (i) within the catalytic kinase domain, (ii) in the C-terminal kinase region, and (iii) in regulatory domains. Some of the kinases downregulated by Pin1 activity are tumor-suppressing, and all kinases upregulated by Pin1 activity are functionally pro-oncogenic. These findings further reinforce the rationale for developing Pin1-specific inhibitors as attractive pharmaceuticals for cancer therapy.
肽基脯氨酰顺反异构酶 Pin1 与脯氨酸导向的激酶和磷酸酶合作,调节多种致癌途径。Pin1 特异性识别蛋白质中的磷酸化 Ser/Thr-Pro 基序,并催化其顺反异构化。Pin1 催化的构象变化决定了许多蛋白质底物的稳定性、活性和亚细胞定位。我们对受 Pin1 调节且其 Pin1 结合位点已被鉴定的真核蛋白激酶进行了调查。我们的分析表明,Pin1 在激酶中的靶位点并非完全局限于这些酶的固有无序区域内。相反,它们基于位置分为三组:(i) 在催化激酶结构域内,(ii) 在 C 端激酶区域内,以及 (iii) 在调节结构域内。Pin1 活性下调的一些激酶是肿瘤抑制因子,而 Pin1 活性上调的所有激酶在功能上都是致癌的。这些发现进一步强化了开发 Pin1 特异性抑制剂作为癌症治疗有吸引力的药物的基本原理。